BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.408
-0.041 (-9.03%)
At close: Feb 21, 2025, 4:00 PM
0.407
-0.001 (-0.34%)
After-hours: Feb 21, 2025, 6:08 PM EST

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $23.68 million. The enterprise value is -$31.59 million.

Market Cap 23.68M
Enterprise Value -31.59M

Important Dates

The next estimated earnings date is Tuesday, March 25, 2025, after market close.

Earnings Date Mar 25, 2025
Ex-Dividend Date n/a

Share Statistics

BioAtla has 58.02 million shares outstanding. The number of shares has increased by 3.25% in one year.

Current Share Class 58.02M
Shares Outstanding 58.02M
Shares Change (YoY) +3.25%
Shares Change (QoQ) +0.25%
Owned by Insiders (%) 6.75%
Owned by Institutions (%) 26.58%
Float 45.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.79
Forward PS n/a
PB Ratio 0.86
P/TBV Ratio 1.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.05.

Current Ratio 3.11
Quick Ratio 2.90
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -139.06% and return on invested capital (ROIC) is -88.52%.

Return on Equity (ROE) -139.06%
Return on Assets (ROA) -50.47%
Return on Invested Capital (ROIC) -88.52%
Return on Capital Employed (ROCE) -201.61%
Revenue Per Employee $169,231
Profits Per Employee -$1.26M
Employee Count 65
Asset Turnover 0.10
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.07% in the last 52 weeks. The beta is 1.12, so BioAtla's price volatility has been higher than the market average.

Beta (5Y) 1.12
52-Week Price Change -83.07%
50-Day Moving Average 0.67
200-Day Moving Average 1.54
Relative Strength Index (RSI) 32.45
Average Volume (20 Days) 834,050

Short Selling Information

The latest short interest is 4.38 million, so 7.54% of the outstanding shares have been sold short.

Short Interest 4.38M
Short Previous Month 5.06M
Short % of Shares Out 7.54%
Short % of Float 9.63%
Short Ratio (days to cover) 4.17

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$81.82 million in losses. Loss per share was -$1.70.

Revenue 11.00M
Gross Profit -63.12M
Operating Income -86.24M
Pretax Income -104.56M
Net Income -81.82M
EBITDA -85.17M
EBIT -86.24M
Loss Per Share -$1.70
Full Income Statement

Balance Sheet

The company has $56.52 million in cash and $1.25 million in debt, giving a net cash position of $55.27 million or $0.95 per share.

Cash & Cash Equivalents 56.52M
Total Debt 1.25M
Net Cash 55.27M
Net Cash Per Share $0.95
Equity (Book Value) 22.97M
Book Value Per Share 0.48
Working Capital 41.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.08 million and capital expenditures -$8,000, giving a free cash flow of -$85.08 million.

Operating Cash Flow -85.08M
Capital Expenditures -8,000
Free Cash Flow -85.08M
FCF Per Share -$1.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -783.95%
Pretax Margin -743.79%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.25%
Shareholder Yield -3.25%
Earnings Yield -345.51%
FCF Yield -359.30%

Analyst Forecast

The average price target for BioAtla is $5.00, which is 1,125.19% higher than the current price. The consensus rating is "Buy".

Price Target $5.00
Price Target Difference 1,125.19%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -18.73%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioAtla has an Altman Z-Score of -12.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.69
Piotroski F-Score n/a